A cell becomes senescent given sufficient stress, molecular damage, or on reaching the Hayflick limit on replication. A senescent cell ceases replication, grows in size, and secretes a potent mix of pro-growth, pro-inflammatory signals. In a young individual, senescent cells are rapidly removed by the immune system, but this clearance slows with age. Senescent cells accumulate as a result in tissues throughout the aging body. The greater the number of senescent cells, the more disruptive their signaling becomes, changing the behavior of surrounding cells for the worse, degrading tissue structure, and rousing the immune system into a harmful state of constant inflammatory behavior. Studies have shown that selective clearance of senescent cells in older mice improves health, extends life, and turns back many aspects of age-related disease.
Today's open access paper reviews what is know of the bidirectional relationship between the burden of cellular senescence and state of the aging immune system. Senescent cells degrade the performance of the immune system, while the aging of the immune system allows greater numbers of senescent cells to accumulate. Like many of the interacting aspects of aging, each side exacerbates the other in a feedback loop that accelerates over time. Under the hood, the details are far more complex than this simple summary of the situation, of course, and there much is yet to be mapped and understood. Still, what is known more than justifies a far greater level of attention and funding to be given to clinical trials of senolytic therapies to clear senescent cells.
Immunological consequences of senescence in physiology and pathology
Cellular senescence is a sublethal stress response characterized by a durable cell-cycle arrest and the acquisition of a complex secretory program known as the senescence-associated secretory phenotype (SASP), which can profoundly influence local and systemic immunity. In physiological contexts - including embryonic development, tissue repair, and acute tumour suppression - senescent cells coordinate the recruitment and activation of immune cells, enabling their timely immune-mediated clearance and facilitating tissue remodelling and restoration of homeostasis. However, during aging and chronic disease, immune surveillance mechanisms frequently become compromised, allowing senescent cells to accumulate and persist within tissues.
The persistence of senescent cells results in sustained SASP signalling that promotes chronic inflammation, immune dysfunction, and tissue remodelling processes linked to fibrosis, metabolic impairment, tumour progression, and defective tissue repair. In parallel, increasing evidence indicates that immune cells themselves can acquire senescent or senescence-like states, thereby weakening immunosurveillance and generating self-reinforcing feedback loops that further amplify senescent cell accumulation and tissue dysfunction.
The relationship between senescent cells and the immune system is reciprocal. Immune surveillance governs whether the senescence response is resolved or persists, yet immune cells themselves can adopt senescence-associated features that remodel tissue environments and propagate senescence systemically. Age-related decline or dysfunction within immune compartments can amplify inflammatory signalling, shift immune tolerance and generate niches that favour senescent-cell persistence, establishing feedback loops between immune aging and cellular senescence. Together, these observations position senescence not as an isolated cell-intrinsic programme but as a process shaped by continuous dialogue with the immune system. The strength of this senescence-immune crosstalk is shifting the therapeutic paradigm from classical senolytics toward immuno-senolytic strategies aimed at reactivating endogenous immune surveillance or deploying engineered immune cells to selectively eliminate senescent populations.
View the full article at FightAging
